2-((1S,6R)-6-(DIFLUOROMETHYL)-3-AZABICYCLO(4.1.0)HEPTAN-3-YL)-N-(2-(4,4-DIFLUOROPIPERIDIN-1-YL)-6-METHYLPYRIMIDIN-4-YL)-4-(2-HYDROXYETHYLSULFONYLAMINO)BENZAMIDE
UNII 32A745B9S7
Substance Identification & Data
This profile provides standardized clinical and technical data for 2-((1s,6r)-6-(difluoromethyl)-3-azabicyclo(4.1.0)heptan-3-yl)-n-(2-(4,4-difluoropiperidin-1-yl)-6-methylpyrimidin-4-yl)-4-(2-hydroxyethylsulfonylamino)benzamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 32A745B9S7.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3030452-38-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C26H32F4N6O4S YRVQXJALDPONGQ-NSYGIPOTSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 2-((1s,6r)-6-(difluoromethyl)-3-azabicyclo(4.1.0)heptan-3-yl)-n-(2-(4,4-difluoropiperidin-1-yl)-6-methylpyrimidin-4-yl)-4-(2-hydroxyethylsulfonylamino)benzamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.